← Back to Screener
Labcorp Holdings Inc. (LH)
Price$265.15
Value ScoreC
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-9.28%
Price vs S&P 500 (4W)4.35%
VGM Score45.75
Market Capitalization$21.74B
P/E Ratio (Annual)24.81x
Indicated Dividend Yield (Annual)1.10%
All Metrics
P/CF (Annual)13.25x
Book Value / Share (Quarterly)$106.06
P/TBV (Annual)4.14x
Indicated Dividend (Annual)$2.88
Revenue Growth (3Y)5.55%
Cash Flow / Share (Quarterly)$16.82
Payout Ratio (TTM)25.52%
Price vs S&P 500 (YTD)-2.47%
Gross Margin (TTM)28.83%
Net Profit Margin (TTM)6.66%
EPS (TTM)$11.29
10-Day Avg Trading Volume0.60M
EPS Excl Extra (TTM)$11.29
Revenue Growth (5Y)-0.04%
EPS (Annual)$10.46
Dividend / Share (Annual)$2.91
ROI (Annual)6.14%
Gross Margin (Annual)28.76%
Net Profit Margin (5Y Avg)8.87%
Cash / Share (Quarterly)$11.92
P/E Basic Excl Extra (TTM)23.09x
Revenue Growth QoQ (YoY)5.75%
EPS Growth (5Y)-8.01%
P/E Normalized (Annual)24.81x
ROA (Last FY)4.77%
Revenue Growth TTM (YoY)7.34%
EBITD / Share (TTM)$20.68
ROE (5Y Avg)12.11%
Operating Margin (TTM)10.18%
Cash Flow / Share (Annual)$14.67
P/B Ratio2.49x
P/B Ratio (Quarterly)2.51x
Net Income / Employee (Annual)$12,300
EV / Revenue (TTM)1.92x
Net Interest Coverage (TTM)5.18x
ROA (TTM)5.10%
EPS Growth QoQ (YoY)32.75%
EV / EBITDA (TTM)15.74x
EPS Incl Extra (Annual)$10.46
Current Ratio (Annual)1.42x
Quick Ratio (Quarterly)1.30x
3-Month Avg Trading Volume0.65M
52-Week Price Return5.16%
EV / Free Cash Flow (Annual)22.52x
P/E Incl Extra (TTM)23.09x
Revenue / Employee (TTM)$199,200
Tangible BV / Share (Quarterly)$61.88
P/S Ratio (Annual)1.56x
Asset Turnover (Annual)0.76x
52-Week High$293.72
Operating Margin (5Y Avg)11.91%
EPS Excl Extra (Annual)$10.46
CapEx CAGR (5Y)2.63%
Tangible BV CAGR (5Y)-1.43%
26-Week Price Return-1.35%
Quick Ratio (Annual)0.99x
13-Week Price Return-3.90%
Total Debt / Equity (Annual)0.66x
Current Ratio (Quarterly)1.73x
Enterprise Value$27.16B
Revenue / Share Growth (5Y)3.14%
Asset Turnover (TTM)0.77x
Book Value / Share Growth (5Y)1.78%
Revenue / Employee (Annual)$196,500
Inventory Turnover (Annual)19.34x
Pretax Margin (Annual)7.94%
Cash / Share (Annual)$6.48
3-Month Return Std Dev21.74%
Gross Margin (5Y Avg)30.71%
Net Income / Employee (TTM)$13,300
EBITDA CAGR (5Y)-9.74%
EBITDA Interim CAGR (5Y)-16.88%
ROE (Last FY)10.17%
Net Interest Coverage (Annual)5.36x
EPS Basic Excl Extra (Annual)$10.46
P/FCF (TTM)15.71x
Receivables Turnover (TTM)5.99x
EV / Free Cash Flow (TTM)19.63x
Total Debt / Equity (Quarterly)0.73x
EPS Incl Extra (TTM)$11.29
Receivables Turnover (Annual)6.40x
ROI (TTM)6.51%
P/S Ratio (TTM)1.54x
Pretax Margin (5Y Avg)10.48%
Revenue / Share (Annual)$166.49
Tangible BV / Share (Annual)$61.12
Forward P/E13.97x
Free OCF CAGR (5Y)-7.21%
Price vs S&P 500 (52W)-19.21%
P/E Ratio (TTM)23.09x
EPS Growth TTM (YoY)30.16%
Year-to-Date Return5.69%
5-Day Price Return3.22%
EPS Normalized (Annual)$10.46
ROA (5Y Avg)5.87%
Net Profit Margin (Annual)6.28%
Month-to-Date Return1.96%
Cash Flow / Share (TTM)$13.73
EBITD / Share (Annual)$19.87
EPS Growth (3Y)-9.18%
Operating Margin (Annual)9.92%
LT Debt / Equity (Annual)0.59x
P/CF (TTM)11.99x
ROI (5Y Avg)7.56%
P/E Excl Extra (TTM)23.09x
LT Debt / Equity (Quarterly)0.67x
EPS Basic Excl Extra (TTM)$11.29
P/TBV (Quarterly)4.31x
Payout Ratio (Annual)27.46%
P/B Ratio (Annual)2.41x
Dividend / Share (TTM)$2.89
Inventory Turnover (TTM)20.42x
Pretax Margin (TTM)8.14%
Book Value / Share (Annual)$104.86
Price vs S&P 500 (13W)-12.16%
Net Margin Growth (5Y)-10.81%
Dividend Yield (TTM)1.11%
Beta0.88x
P/FCF (Annual)18.03x
Revenue / Share (TTM)$170.62
ROE (TTM)10.91%
52-Week Low$241.81
vGradeC
gGradeD
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 264.25est. 4.21
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.14
4.14
4.14
4.14
Industry Peers — Health Services(28)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
LHLabcorp Holdings Inc. | C | D | C | $265.15 |
| NTRANatera, Inc. Common Stock | F | A | C | $215.31 |
| DGXQuest Diagnostics Inc. | C | D | C | $200.29 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| GHGuardant Health, Inc. Common Stock | F | A | B | $125.61 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | D | $16.49 |
| CELCCelcuity Inc. Common Stock | — | — | C | $88.28 |
| RDNTRadNet, Inc. Common Stock | D | C | C | $54.34 |
| VCYTVeracyte, Inc. | D | A | B | $48.73 |
| GRALGRAIL, Inc. Common Stock | D | A | C | $59.98 |
| FTREFortrea Holdings Inc. Common Stock | B | F | A | $16.08 |
About
Labcorp is one of the two largest independent clinical laboratory companies in the United States, commanding approximately 20% of the independent lab market. The company operates roughly 2,000 patient-service centers and offers a comprehensive suite of 5,000 clinical tests, from routine blood and urine analysis to advanced oncology and genomic testing.